Suboptimal Response to or Failure of Imatinib Treatment for Chronic Myeloid Leukemia: What Is the Optimal Strategy? Elias Jabbour, MD, Jorge E. Cortes,

Slides:

Advertisements

Similar presentations

Malignant Hypertension as a Presenting Symptom of Takayasu Arteritis Talya Wolak, MD, Gabriel Szendro, MD, Luis Golcman, MD, Esther Paran, MD Mayo Clinic.

Advertisements

Clinical Pharmacology, Uses, and Adverse Reactions of Iodinated Contrast Agents: A Primer for the Non-radiologist Jeffrey J. Pasternak, MD, Eric E. Williamson,

My Treatment Approach to Hairy Cell Leukemia Rahul R. Naik, MD, Alan Saven, MD Mayo Clinic Proceedings Volume 87, Issue 1, Pages (January 2012) DOI:

Managing Cancer Pain: Basic Principles and Invasive Treatments

Ductal Carcinoma in Situ of the Breast

Pleural Effusion in Dasatinib-Treated Patients With Chronic Myeloid Leukemia in Chronic Phase: Identification and Management Jorge E. Cortes, Carlos.

Cidofovir Treatment of Progressive Multifocal Leukoencephalopathy in a Patient Receiving Highly Active Antiretroviral Therapy Raymund R. Razonable, MD,

J. Eric Ahlskog, PhD, MD Mayo Clinic Proceedings

Family-Based Therapy for Adolescents With Anorexia Nervosa

Evaluation of Proteinuria

Jean L. Chan, MD, Martin J. Abrahamson, MD Mayo Clinic Proceedings

Diagnostic Options for Assessment of Postmenopausal Bleeding

Nonsteroidal Anti-Inflammatory Drug-Induced Enteropathy: Case Discussion and Review of the Literature Paul Y. Kwo, M.D., William J. Tremaine, M.D. Mayo.

Treatment of Nightmares With Prazosin: A Systematic Review

William L. Lanier, MD Mayo Clinic Proceedings

Diagnosis and Management of Chronic Kidney Disease

Minimal cross-intolerance with nilotinib in patients with chronic myeloid leukemia in chronic or accelerated phase who are intolerant to imatinib by Jorge.

Mucinous Neoplasm of the Appendix and Pseudomyxoma Peritonei

A Comparison of Long- and Short-Acting Opioids for the Treatment of Chronic Noncancer Pain: Tailoring Therapy to Meet Patient Needs Charles E. Argoff,

Treatment of Alcohol Withdrawal in Hospitalized Patients

Review of Childhood Obesity

Ayalew Tefferi, M.D. Mayo Clinic Proceedings

Management of Adult Onset Seizures

Obsessive Compulsive Disorder: A Clinical Update

Safety and Efficacy of Haploidentical Stem Cell Transplantation for Advanced Chronic Myeloid Leukemia Kehinde Adekola, MD, Antonio di Stasi, MD, Roberto.

Corticosteroids in the Treatment of Alcohol-Induced Rhabdomyolysis

George Dailey, MD Mayo Clinic Proceedings

Palliative Care and Hospice Programs

Cannabinoid Hyperemesis: A Case Series of 98 Patients

Topical Analgesics in the Management of Acute and Chronic Pain

Final Report Of Single-Center Study Of Chemotherapy Plus Dasatinib For The Initial Treatment Of Patients With Philadelphia-Chromosome Positive Acute Lymphoblastic.

Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: a randomized phase 2 trial by Hagop Kantarjian,

Photodynamic Therapy for Early Stage Central Type of Lung Cancer

Pancreatic Ductal Adenocarcinoma

Ayalew Tefferi, MD Mayo Clinic Proceedings

The Red Scalp Sign Mayo Clinic Proceedings

Delayed achievement of cytogenetic and molecular response is associated with increased risk of progression among patients with chronic myeloid leukemia.

MIGUEL A. VALDOVINOS, M. D. , MICHAEL CAMILLERI, M. D. , BRUCE R

Treating Tobacco Dependence in Light of the 2008 US Department of Health and Human Services Clinical Practice Guideline J. Taylor Hays, MD, Jon O. Ebbert,

Refurbishing Mayo Clinic Proceedings:

Best Practices for Patients With Chronic Migraine

Management of Adult Onset Seizures

Complex Regional Pain Syndrome

Osteoporosis Associated With Megestrol Acetate

Diabetic Mastopathy Mayo Clinic Proceedings

Simon M. Glynn, MD, Sean J. Pittock, MD, Steven A. Vernino, MD, PhD

Novel Risk Factors for Atherosclerosis

Allen D. Seftel, MD, Martin Kathrins, MD, Craig Niederberger, MD

Hepatocellular Carcinoma

68-Year-Old Man With Chronic Diarrhea, Nausea, and Vomiting

Methylphenidate: Its Pharmacology and Uses

Postoperative Trouble

Pulmonary Tumor Embolism of Unknown Origin

Medical Treatment of Overactive Bladder: In Response

Mantle Cell Involvement of the Spleen

Squamous Cell Carcinoma of the Tongue

High Levels of Circulating HSP70 Levels in Patients with Chronic Myeloid Leukemia and Correlation with Resistance to Therapy with Imatinib. by Richard.

Preoperative Smoking Cessation: The Role of the Primary Care Provider

Medical Student Distress: Causes, Consequences, and Proposed Solutions

Pneumococcal Bacteremia: Lessons Learned, Yet More to Learn

Guru Sonpavde, MD, Teresa G. Hayes, MD Mayo Clinic Proceedings

Clomiphene-Induced Severe Hypertriglyceridemia and Pancreatitis

Surviving Heart Failure: Robert L. Frye Lecture

Managing Cancer Pain: Basic Principles and Invasive Treatments

Treatment of Antineutrophil Cytoplasm Autoantibody-Associated Systemic Vasculitis: Initiatives of the European Community Systemic Vasculitis Clinical.

The Obesity Paradox: Perception vs Knowledge

Diagnosis and Management of Headache in Older Adults

A New Look at Osteoporosis Outcomes: The Influence of Treatment, Compliance, Persistence, and Adherence Enkhe Badamgarav, MD, MPH, Lorraine A. Fitzpatrick,

Acute and Chronic Seizures in Patients Older Than 60 Years

Mayo Clinic Proceedings 2012: “A New Era in Journal Stewardship”

Presentation transcript:

Suboptimal Response to or Failure of Imatinib Treatment for Chronic Myeloid Leukemia: What Is the Optimal Strategy? Elias Jabbour, MD, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD Mayo Clinic Proceedings Volume 84, Issue 2, Pages 161-169 (February 2009) DOI: 10.4065/84.2.161 Copyright © 2009 Mayo Foundation for Medical Education and Research Terms and Conditions

FIGURE Duration of major cytogenetic response in the randomized phase 2 trial of dasatinib vs high-dose imatinib in patients with chronic-phase chronic myeloid leukemia after failure of standard-dose imatinib therapy. From Blood.49 Mayo Clinic Proceedings 2009 84, 161-169DOI: (10.4065/84.2.161) Copyright © 2009 Mayo Foundation for Medical Education and Research Terms and Conditions